From 1800, arterial thrombosis and venous thrombosis were increasingly recognised as causes of sudden death. By 1960, they had replaced infections as the commonest cause of death in Scotland and the UK, as in many developed countries. The important contributions of Scotland’s doctors between 1800 and 1960 to the knowledge of thrombosis, and to its treatment and prevention by anticoagulant drugs, are reviewed.
GoodmanLR. In search of venous thromboembolism: the first 2913 years. Am J Radiol2013; 201: W576–81.
2.
DouglasAS. History of venous thrombo-embolic disease 1750–1900. Scott Med J1978; 233: 315–7.
3.
BurnsA. Observations on Some of the Most Frequent and Important Diseases of the Heart. Edinburgh: Thomas Bryce; 1809.
4.
BedfordDE. The surgeon cardiologists of the 19th century. Br Heart J1967; 29: 461–3.
5.
FyeWB. Allan Burns. Clin Cardiol1990; 13: 301–2.
6.
BuchananA. Contributions to the physiology and pathology of the animal fluids; containing experiments and observations on the effects of certain substances upon the blood; and on the coagulation of the blood. London Med Gaz1836; 18: 50–4.
7.
Von RokitanskyK. Handbuch der Pathologischen Anatomie, vol. 2. Vienna: Braunmuller and Seidel; 1844.
8.
VirchowR. Weitere Untersuchungen ueber die Verstopfung der Lungarterien und ihre Folge. Traube’s Beitraege exp Path u Physiol1846; 2: 21–31.
9.
ListerJ. On the coagulation of the blood. Proc R Soc Lond1863; 12: 580–61.
10.
StevenJL. Fibrin degeneration and allied lesions of the heart, and their association with disease of the coronary arteries. Lancet1887; 3354: 1153–6; 3355: 1205–8; 3356: 1255–7.
11.
StevenJL. The pathology of fibroid degeneration (fibrous transformation) of the heart with 21 cases. J Pathol Bacteriol1894; 2: 190–204.
12.
MairA. Sir James Mackenzie MD General Practitioner 1853–1925. Edinburgh and London: Churchill Livingstone; 1973.
13.
CobbeSMLoweGDO, editors. Atrial fibrillation in hospital and general practice: the Sir James Mackenzie consensus conference. J R Coll Physicians Edinb1999; 29: 1–34.
14.
McNaughtonJ. The St Andrews Institute for clinical research: an early experiment in collaboration. Med Hist2002; 46: 549–68.
15.
WaterstonDOrrJCappellDF. Sir James Mackenzie’s heart. Br Heart J1939; 1: 237–48.
16.
LoweG. Tayside’s contribution to the early development of cardiology. J R Coll Physicians Edinb2012; 42: 69–74.
17.
GilchristAR. The clinical features of myocardial infarction. Edinb Med J1930; 37: T185–202.
18.
HillIG. Multiple-lead electrocardiograms. Lancet1950; I (6613): 985–91; I (6614): 1027–33.
19.
WrightISMarpleCDBeckDF. Anticoagulant therapy of coronary thrombosis with myocardial infarction. J Am Med Assoc1948; 138: 1074–9.
20.
TullochJAGilchristAR. Anticoagulants in treatment of coronary thrombosis. Br Med J1950; 2: 965–71.
21.
OwrenPA.Long term anticoagulant therapy in coronary artery disease. Schweiz Med Wschr1954; 84: 822–7.
22.
MeadeTW. The epidemiology of atheroma, thrombosis and ischaemic heart disease. In BloomALForbesCDThomasDPTuddenhamEGD, editors. Haemostasis and Thrombosis. 3rd ed. Edinburgh: Churchill Livingstone; 1994. p. 1199–227.
23.
LoweGDOLudlamCA. Haemophilia in Scotland. Rep Proc Scott Soc Hist Med2021: 48–61.
24.
WalkerW, editor. Thrombosis and Anticoagulant Therapy. St Andrews: University of St Andrews; 1960.
25.
WalkerWHunterRB. The mode of action of phenylindanedione. J Clin Pathol1954; 7: 249–51.
26.
WalkerWHunterRB. Action of coumarin anticoagulants on a possible new serum clotting factor. Nature1954; 173; 1192.
27.
HunterRBWalkerW. The control of anticoagulant therapy in myocardial infarction. Br Med J1954; 2: 197–9.
ToddAS. The histological localisation of fibrinolysin activator. J Pathol Bacteriol1959; 78: 281–3.
32.
VerstraeteMAmeryAVermylenJ. Feasibility of adequate thrombolytic therapy with streptokinase in peripheral arterial occlusions. I. Clinical and arteriographic results. Br Med J1963; 1: 1499–504.
33.
McNicolGPReidWBainWH, et al. Treatment of peripheral arterial occlusion by streptokinase perfusion. Br Med J1963; 1: 1508–12.
34.
Report of the Working Party on Anticoagulant Therapy to the Medical Research Council. An assessment of long term anticoagulant administration after cardiac infarction. Br Med J1959; 1: 803–10.
